Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction

Peking University

Status: Completed

Conditions: Dry Eye Syndrome

Treatments: Device: intense pulsed light; Drug: Tobramycin and Dexamethasone Ophthalmic Ointment

Study type: Interventional

Funder types: Other

Identifiers

NCT02958514

2016154

Details and patient eligibility

About

This study aims to evaluate the efficacy of intense pulsed light in treating dry eye caused by meibomian gland dysfunction and make a comparison between the traditional treatment.

Enrollment: 20 patients

Sex: All

Ages: 26 to 78 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with dry eye syndrome and diagnosed as MGD

Exclusion criteria

• an infection or inflammatory disease;
• ocular surgical history with in the last 3 months
• SGOGREN SYNDROME

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

20 participants in 2 patient groups

traditional treatment group

Other group

Description:

Subjects in this group are treated by tobramycin and dexamethasone ophthalmic ointment qn and artificial tears qid.

Treatment:

Drug: Tobramycin and Dexamethasone Ophthalmic Ointment

IPL treatment group

Experimental group

Description:

Subjects in this group are treated with 3 cycles of intense pulsed light of 4 weeks interval and artificial tears qid.

Treatment:

Device: intense pulsed light